Provided by Tiger Trade Technology Pte. Ltd.

Immunic, Inc.

1.09
-0.1700-13.49%
Post-market: 1.100.0113+1.04%19:58 EDT
Volume:3.38M
Turnover:3.89M
Market Cap:142.21M
PE:-1.75
High:1.28
Open:1.26
Low:1.09
Close:1.26
52wk High:1.51
52wk Low:0.5062
Shares:130.46M
Float Shares:95.79M
Volume Ratio:1.70
T/O Rate:3.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6241
EPS(LYR):-0.6241
ROE:-1653.15%
ROA:-198.76%
PB:-21.31
PE(LYR):-1.75

Loading ...

Immunic Inc. CEO to Join Evercore ISI Healthcare Conference Fireside Chat

Reuters
·
Nov 26, 2025

Immunic price target lowered to $8 from $10 at H.C. Wainwright

TIPRANKS
·
Nov 14, 2025

Immunic, Inc. : H.c. Wainwright Cuts Target Price to $8 From $10

THOMSON REUTERS
·
Nov 14, 2025

Immunic’s Promising Market Potential: Buy Rating Backed by Vidofludimus Calcium’s Efficacy, Safety, and Strategic Financial Path

TIPRANKS
·
Nov 14, 2025

Immunic Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Nov 13, 2025

Biotech Immunic's Q3 net loss widens

Reuters
·
Nov 13, 2025

Immunic reports Q3 EPS (13c), consensus (18c)

TIPRANKS
·
Nov 13, 2025

Immunic Q3 EPS $(0.13) Beats $(0.18) Estimate

Benzinga
·
Nov 13, 2025

Immunic Inc. reports third quarter net loss of $25.6 million

Reuters
·
Nov 13, 2025

Immunic Inc. Reports Third Quarter 2025 Financial Results and Updates on Multiple Sclerosis Trials

Reuters
·
Nov 13, 2025

Immunic Q3 Income From Operations USD -25.993 Million

THOMSON REUTERS
·
Nov 13, 2025

Immunic Q3 Basic EPS USD -0.13

THOMSON REUTERS
·
Nov 13, 2025

Immunic- Top-Line Data From Twin Phase 3 Ensure-1 and Ensure-2 Trials in Rms Expected by 2026 End

THOMSON REUTERS
·
Nov 13, 2025

Immunic: Co Does Not Have Adequate Liquidity to Fund Its Operations for at Least 12 Months From Sept 30, 2025, Without Raising Additional Capital

THOMSON REUTERS
·
Nov 13, 2025

Immunic initiated with a Buy at Roth Capital

TIPRANKS
·
Nov 07, 2025

Immunic Inc. to Participate in BIO-Europe Conference

Reuters
·
Oct 29, 2025

Immunic initiated with a Buy at Ladenburg

TIPRANKS
·
Oct 17, 2025

Immunic management to meet with B. Riley

TIPRANKS
·
Oct 10, 2025

Immunic Inc. to Present Data on IMU-856 at United European Gastroenterology Week

Reuters
·
Oct 01, 2025

Immunic Initiated at Buy by Chardan Capital

Dow Jones
·
Sep 29, 2025